Earthworms could become unexpected allies in the global fight against antibiotic resistance, by helping farmers turn manure ...

Using a tiny, acid-tolerant yeast, scientists have demonstrated a cost-effective way to make disposable diapers, ...

A new technique which slashes the time taken to diagnose microbial infections from days to minutes could help save lives and ...

The utilization of biodegradable biomaterials as a therapeutic modality for musculoskeletal tissue regeneration has emerged as a promising avenue for ...

Understand the role of reproductive biotech in overcoming biological limits in fertility treatments and enhancing success ...

French biotech (ABVX) has emerged as the most likely acquisition target among biotechs in 2026, significantly outpacing others, while liver drug developer Madrigal Pharmaceuticals (MDGL) has become ...

Healthcare and biotech stocks have had a rough run since the giddy heights of the Covid pandemic. But now could be the perfect time to consider investing in these beaten-down but high-growth sectors.

Swiss oncology powerhouse BeOne Medicines (ONC) has emerged as one of 2025's top performers in a sector often plagued by volatility. Year-to-date, ONC shares have rocketed 75%, outpacing many peers ...

A medical device company from Ireland, a biotech startup developing cancer therapeutics from Pennsylvania and a venture studio focused on women’s health from Massachusetts are among eight recipients ...

Biotech-based exchange-traded fund (ETF) iShares Biotechnology ETF IBB has rallied about 35% over the past six months (as of Nov. 20, 2025), outperforming SPDR S&P 500 ETF Trust SPY (up 12%). Year to ...